Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pfizer (DE:PFE)
XETRA:PFE
Holding DE:PFE?
Track your performance easily
PFE Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€23.53 - €29.50
Previous Close€26.43
Volume38.76K
Average Volume (3M)63.16K
Market Cap
€149.40B
Enterprise Value€207.48B
Total Cash (Recent Filing)$7.10B
Total Debt (Recent Filing)$69.45B
Price to Earnings (P/E)―
Beta0.04
Next Earnings
Oct 29, 2024EPS Estimate
€0.57Next Dividend Ex-Date
Nov 08, 2024Dividend Yield5.87%
Share Statistics
EPS (TTM)-0.43
Shares Outstanding5,666,695,064
10 Day Avg. Volume33,646
30 Day Avg. Volume63,165
Standard Deviation0.08
R-Squared0.00317
Alpha0.00227
Financial Highlights & Ratios
Price to Book (P/B)1.72
Price to Sales (P/S)2.90
Price to Cash Flow (P/CF)-22.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.73
Enterprise Value/Gross Profit6.19
Enterprise Value/Ebitda25.96
Forecast
1Y Price Target
€30.09Price Target Upside12.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering21
Pfizer News
Bulls Say, Bears Say
Bulls Say
COVID-19 Vaccine SalesEarlier COVID surge & vaccinations could pull forward COVID sales to Q3, resulting in $250M upside to consensus.
Product PotentialPonsegromab offers blockbuster potential since there is no approved treatment for cancer cachexia in the U.S. or Europe.
Shareholder ConfidenceFormer Pfizer executives support the current leadership and expect them to create shareholder value over time.
Bears Say
Clinical Trials And Drug DevelopmentPfizer had to discontinue the development of lotiglipron due to liver toxicity concerns.
Financial PerformanceDespite significant cost-cutting measures, Pfizer is not expected to generate significant earnings growth post-2027, with revenues predicted to be flat or declining.
Vaccine SalesOther vaccines could be weak, as Abrysvo sales could miss by $40M due to recent surge in COVID vaccinations putting pressure on RSV vaccine demand.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.03% Insiders
19.00% Mutual Funds
1.66% Other Institutional Investors
57.75% Public Companies and
Individual Investors
PFE FAQ
What was Pfizer’s price range in the past 12 months?
Pfizer lowest stock price was €23.53 and its highest was €29.50 in the past 12 months.
What is Pfizer’s market cap?
Currently, no data Available
When is Pfizer’s upcoming earnings report date?
Pfizer’s upcoming earnings report date is Oct 29, 2024 which is 3 days ago.
How were Pfizer’s earnings last quarter?
Pfizer released its earnings results on Jul 30, 2024. The company reported €0.556 earnings per share for the quarter, beating the consensus estimate of €0.425 by €0.132.
Is Pfizer overvalued?
According to Wall Street analysts Pfizer’s price is currently Undervalued.
Does Pfizer pay dividends?
Pfizer pays a Quarterly dividend of €0.39 which represents an annual dividend yield of 5.87%. See more information on Pfizer dividends here
What is Pfizer’s EPS estimate?
Pfizer’s EPS estimate is €0.57.
How many shares outstanding does Pfizer have?
Pfizer has 5,666,695,000 shares outstanding.
What happened to Pfizer’s price movement after its last earnings report?
Pfizer reported an EPS of €0.556 in its last earnings report, beating expectations of €0.425. Following the earnings report the stock price went down -0.405%.
Which hedge fund is a major shareholder of Pfizer?
Among the largest hedge funds holding Pfizer’s share is Diamond Hill Capital Management Inc. It holds Pfizer’s shares valued at 445M.
---
Pfizer Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€30.09 (12.79% Upside)
€30.09 (12.79% Upside)
Blogger Sentiment
Bullish
DE:PFE Sentiment 83%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $147.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-1.95%
12-Months-Change
Fundamentals
Return on Equity
-2.78%
Trailing 12-Months
Asset Growth
-1.81%
Trailing 12-Months
Company Description
Pfizer
Pfizer Inc. develops, manufactures and sells healthcare products, including innovative medicines and vaccines. Its key focus areas include oncology, inflammation & immunology, rare disease, vaccines and internal medicine. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
---
PFE Company Deck
---
PFE Earnings Call
Q2 2024
0:00 / 0:00
---
PFE Revenue Breakdown
52.29% Primary Care
25.59% Specialty Care
19.88% Oncology
2.24% BUSINESS INNOVATION
---
PFE Stock 12 Month Forecast
Average Price Target
€30.09
▲(12.79% Upside)
Technical Analysis
Best Analysts Covering PFE
1 Year
1 Year Success Rate
26/34 ratings generated profit
1 Year Average Return
+5.67%
initiated a buy rating 8 months ago
Copying Vamil Divan's trades and holding each position for 1 Year would result in 76.47% of your transactions generating a profit, with an average return of +5.67% per trade.
---